KevinCWoodMD

PubMed

• 11 citations
  A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
  Tanguy Y. Seiwert, Sara Kochanny, Kevin Wood, Francis P. Worden, Douglas Adkins, James L. Wade, Bethany G. Sleckman, Ryan J. Brisson, Theodore Karrison, Walter M. Stad...> ;Cancer. 2020 Jul 15
• 29 citations
  A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated wit...
  Philip Friedlander, Kevin Wood, Karl Wassmann, Alan M. Christenfeld, Nina Bhardwaj, William Oh> ;Journal for Immunotherapy of Cancer. 2018 Sep 18
• 22 citations
  Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer
  Shalin Shah, Kevin Wood, Brian W. Labadie, Brian Won, Ryan J. Brisson, Theodore Karrison, Thomas A. Hensing, Mark Kozloff, Riyue Bao, Jyoti D. Patel, Jason J. Luke> ;Oncotarget. 2018 Jan 12
• 4 citations
  Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.
  Kevin Wood, Elizabeth Byron, Linda Janisch, Ravi Salgia, Manish R. Sharma> ;American Journal of Clinical Oncology. 2017 Jun 1
• KRAS in Non-Small-Cell Lung Cancer-Reply.
  Kevin Wood, Thomas A. Hensing, Ravi Salgia> ;JAMA Oncology. 2016 Oct 1
• 9 citations
  Optimal Use of BRAF Targeting Therapy in the Immunotherapy Era
  Kevin Wood, Jason J. Luke> ;Current Oncology Reports. 2016 Sep 9
• 118 citations
  Prognostic and Predictive Value in KRAS in Non–Small-Cell Lung Cancer: A Review
  Kevin Wood, Thomas A. Hensing, Raeva Malik, Ravi Salgia> ;JAMA Oncology. 2016 Jun 1
• 5 citations
  Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.
  Heather Landau, Kevin Wood, David J. Chung, Guenther Koehne, Nikoletta Lendvai, Hani Hassoun, Alexander M. Lesokhin, Elizabeth Hoover, Junting Zheng, Sean M. Devlin, S...> ;Leukemia & Lymphoma. 2016 Jan 12
• 11 citations
  A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients
  Alana Dikopf, Kevin Wood, Ravi Salgia> ;Expert Opinion on Drug Safety. 2015 Feb 18
• Join now to see all

Journal Articles

• Reply to "KRAS in non-small cell lung cancer: What about oncogenic addiction and EGFR tyrosine kinase inhibitors?"  
  Wood K, Hensing T, Salgia R, JAMA Oncology, 1/21/2016
• RAS in Non-Small Cell Lung Cancer-Towards Precision Medicine and Therapeutics  
  Wood K, Hensing T,Malik R, Salgia R, JAMA Oncology, 1/1/2016
• Fractionated Stem Cell Infusions for Patients with Plasma Cell Myeloma Undergoing Autologous Hematopoietic Cell Transplantation  
  Landau H, Wood K, Chung D, et al, Leukemia and Lymphoma, 1/1/2016
• A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients  
  Dikopf A, Wood K, Salgia R, Expert Opin Drug Saf, 1/1/2015
• Join now to see all

Abstracts/Posters

• Clinical Characteristics of Acquired Resistance with anti-PD-1/PD-L1 in NSCLC.
  Wood K, Hensing T, Patel J, IASCL Chicago Conference, Chicago, IL, 1/1/2016
• Concurrent EGFR and ALK mutations in KRAS-mutant adenocarcinomas and their clinical behavior.
  Wood K, Hensing, T, Vokes E, Salgia R, IASCL World Conference, Denver, Co, 1/1/2015
• Relationship of KRAS mutations with EGFR and ALK in non-small cell lung cancer.
  Wood K, Hensing, T, Vokes E, Salgia R, IASCL American Conference, Santa Monica, 1/1/2015
• Improving Utilization of Interpreter Services by Medicine Admitting Housestaff.
  Mullally J, Wood K, Bao G, Bender M, Gingras L, Goetz C, Kyi C, Nicewarner H, Schneider Y, Clara Tow C, Lee J, 2014 Integrating Quality Improvement Meeting: Increasing Value and Educating for Quality, Chicago, IL, 1/1/2014
• PET/CT evaluation as a prognostic indicator in relapsed or refractory multiple myeloma.
  Rossi A, Wood K, Niesvizky, R, ASH, 1/1/2013
• Fractionated stem cell infusions for patients with multiple myeloma undergoing autologous stem cell transplant.
  Wood K, Landau H, Giralt, Sergio; et al, American Society for Blood and Bone Marrow Transplant, Salt Lake City, UT, 1/1/2013
• Join now to see all

Lectures

• "Fractionated Stem Cell Infusions for Multiple Myeloma patients undergoing autologous stem cell transplant" 
  1/1/2014

Other

• RAS Mutations in NSCLC. 
  Wood K, Oncology Practice MD-IQ Quiz (online)
  1/2/2016